Pancreatitis clinical trials at UCSF
3 in progress, 2 open to eligible people
SpHincterotomy for Acute Recurrent Pancreatitis
open to eligible people ages 18 years and up
The purpose of this study is to determine if a procedure called Endoscopic Retrograde CholangioPancreatography (ERCP) with sphincterotomy reduces the risk of pancreatitis or the number of recurrent pancreatitis episodes in patients with pancreas divisum. ERCP with sphincterotomy is a procedure where doctors used a combination of x-rays and an endoscope (a long flexible lighted tube) to find the opening of the duct where fluid drains out of the pancreas. People who have been diagnosed with pancreas divisum, have had at least two episodes of pancreatitis, and are candidates for the ERCP with sphincterotomy procedure may be eligible to participate. Participants will be will be randomly assigned to either have the ERCP with sphincterotomy procedure, or to have a "sham" procedure. Participants will have follow up visits 30 days after the procedure, 6 months after the procedure, and continuing every 6 months until a maximum follow-up period of 48 months.
San Francisco, California and other locations
A Prospective Observational Study of TPIAT
open to all eligible people
Multi-center, prospective, observational cohort study of patients undergoing total pancreatectomy with islet autotransplantation (TPIAT)
San Francisco, California and other locations
PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms
Sorry, in progress, not accepting new patients
The aim of this study is to use a validated patient-reported outcome measure to evaluate how many patients have symptoms of pancreatitis after ERCP and how it correlates with their quality of life and productivity.
San Francisco, California and other locations
Our lead scientists for Pancreatitis research studies include Mustafa Arain, MD.
Last updated: